Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features01:24

Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features

Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...
Chronic Obstructive Pulmonary Disease I: Introduction01:23

Chronic Obstructive Pulmonary Disease I: Introduction

Chronic obstructive pulmonary disease is a common, preventable, and treatable respiratory disorder characterized by persistent symptoms and progressive airflow limitation. This limitation results from a combination of small-airway disease (obstructive bronchiolitis) and parenchymal destruction (emphysema), both driven by chronic inflammation from exposure to harmful particles or gases.The disease includes two main pathological entities: emphysema, marked by destruction of alveolar walls and...
Chronic Obstructive Pulmonary Disease-I: Introduction01:20

Chronic Obstructive Pulmonary Disease-I: Introduction

Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
Longitudinal Research02:20

Longitudinal Research

Sometimes we want to see how people change over time, as in studies of human development and lifespan. When we test the same group of individuals repeatedly over an extended period of time, we are conducting longitudinal research. Longitudinal research is a research design in which data-gathering is administered repeatedly over an extended period of time. For example, we may survey a group of individuals about their dietary habits at age 20, retest them a decade later at age 30, and then again...
Chronic Obstructive Pulmonary Disease01:24

Chronic Obstructive Pulmonary Disease

COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Applying machine learning to predict future adherence to physical activity programs.

BMC medical informatics and decision making·2019
Same author

Racial/ethnic and HIV risk category disparities in preexposure prophylaxis discontinuation among patients in publicly funded primary care clinics.

AIDS (London, England)·2019
Same author

Follow-up of incidental pulmonary nodules and association with mortality in a safety-net cohort.

Diagnosis (Berlin, Germany)·2019
Same author

Home-based tuberculosis contact investigation in Uganda: a household randomised trial.

ERJ open research·2019
Same author

Development and Validation of the Personalized Sexual Health Promotion (SexPro) HIV Risk Prediction Model for Men Who Have Sex with Men in the United States.

AIDS and behavior·2019
Same author

Housing First: Unsuppressed Viral Load Among Women Living with HIV in San Francisco.

AIDS and behavior·2019

Related Experiment Video

Updated: May 25, 2026

Development of a Preclinical Inhalation Model to Test Vaporized Cannabis Distillates
06:09

Development of a Preclinical Inhalation Model to Test Vaporized Cannabis Distillates

Published on: May 30, 2025

Association between marijuana exposure and pulmonary function over 20 years.

Mark J Pletcher1, Eric Vittinghoff, Ravi Kalhan

  • 1Department of Epidemiology and Biostatistics, University of California, San Francisco, 185 Berry St, Ste 5700, San Francisco, CA 94107, USA. mpletcher@epi.ucsf.edu

JAMA
|January 12, 2012
PubMed
Summary

Occasional marijuana use did not harm lung function, but heavy use showed mixed results. This study analyzed marijuana

More Related Videos

Impact Assessment of Repeated Exposure of Organotypic 3D Bronchial and Nasal Tissue Culture Models to Whole Cigarette Smoke
09:50

Impact Assessment of Repeated Exposure of Organotypic 3D Bronchial and Nasal Tissue Culture Models to Whole Cigarette Smoke

Published on: February 12, 2015

Administration of Δ9-Tetrahydrocannabinol (THC) in Adolescent and Adult Mice
07:51

Administration of Δ9-Tetrahydrocannabinol (THC) in Adolescent and Adult Mice

Published on: August 1, 2025

Related Experiment Videos

Last Updated: May 25, 2026

Development of a Preclinical Inhalation Model to Test Vaporized Cannabis Distillates
06:09

Development of a Preclinical Inhalation Model to Test Vaporized Cannabis Distillates

Published on: May 30, 2025

Impact Assessment of Repeated Exposure of Organotypic 3D Bronchial and Nasal Tissue Culture Models to Whole Cigarette Smoke
09:50

Impact Assessment of Repeated Exposure of Organotypic 3D Bronchial and Nasal Tissue Culture Models to Whole Cigarette Smoke

Published on: February 12, 2015

Administration of Δ9-Tetrahydrocannabinol (THC) in Adolescent and Adult Mice
07:51

Administration of Δ9-Tetrahydrocannabinol (THC) in Adolescent and Adult Mice

Published on: August 1, 2025

Area of Science:

  • Pulmonary Medicine
  • Epidemiology
  • Toxicology

Background:

  • Marijuana smoke shares constituents with tobacco smoke, raising questions about its impact on lung function.
  • Existing research on marijuana's pulmonary effects is limited and sometimes conflicting.
  • Understanding the dose-response relationship is crucial for public health guidance.

Purpose of the Study:

  • To investigate the association between marijuana exposure (current and lifetime) and pulmonary function.
  • To compare marijuana's effects with those of tobacco smoke on lung capacity.
  • To determine if marijuana use has a linear or nonlinear impact on respiratory health.

Main Methods:

  • Utilized data from the longitudinal Coronary Artery Risk Development in Young Adults (CARDIA) study (20 years).
  • Analyzed pulmonary function measures (FEV(1), FVC) in 5115 participants.
  • Employed mixed linear modeling, accounting for tobacco use as a control, and quantified marijuana exposure in joint-years.

Main Results:

  • Tobacco use was linearly associated with decreased FEV(1) and FVC.
  • Marijuana's association with pulmonary function was nonlinear.
  • Low-level marijuana use showed a slight increase in FEV(1) and FVC; heavy use showed leveling or reversal of these effects, with FVC remaining elevated.

Conclusions:

  • Occasional and low cumulative marijuana use is not linked to adverse pulmonary function.
  • Heavy marijuana use demonstrated complex, non-linear effects on lung function.
  • Further research is needed to fully elucidate the long-term pulmonary consequences of heavy marijuana consumption.